Literature DB >> 23760251

The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule.

Mathieu Mateo1, Chanakha K Navaratnarajah, Sabriya Syed, Roberto Cattaneo.   

Abstract

Wild-type measles virus (MV) strains use the signaling lymphocytic activation molecule (SLAM; CD150) and the adherens junction protein nectin-4 (poliovirus receptor-like 4 [PVRL4]) as receptors. Vaccine MV strains have adapted to use ubiquitous membrane cofactor protein (MCP; CD46) in addition. Recently solved cocrystal structures of the MV attachment protein (hemagglutinin [H]) with each receptor indicate that all three bind close to a hydrophobic groove located between blades 4 and 5 (β4-β5 groove) of the H protein β-propeller head. We used this structural information to focus our analysis of the functional footprints of the three receptors on vaccine MV H. We mutagenized this protein and tested the ability of individual mutants to support cell fusion through each receptor. The results highlighted a strong overlap between the functional footprints of nectin-4 and CD46 but not those of SLAM. A soluble form of nectin-4 abolished vaccine MV entry in nectin-4- and CD46-expressing cells but only reduced entry through SLAM. Analyses of the binding kinetics of an H mutant with the three receptors revealed that a single substitution in the β4-β5 groove drastically reduced nectin-4 and CD46 binding while minimally altering SLAM binding. We also generated recombinant viruses and analyzed their infections in cells expressing individual receptors. Introduction of a single substitution into the hydrophobic pocket affected entry through both nectin-4 and CD46 but not through SLAM. Thus, while nectin-4 and CD46 interact functionally with the H protein β4-β5 hydrophobic groove, SLAM merely covers it. This has implications for vaccine and antiviral strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760251      PMCID: PMC3754078          DOI: 10.1128/JVI.01210-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains.

Authors:  V Lecouturier; J Fayolle; M Caballero; J Carabaña; M L Celma; R Fernandez-Muñoz; T F Wild; R Buckland
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

2.  Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region.

Authors:  T Cathomen; C J Buchholz; P Spielhofer; R Cattaneo
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

3.  A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells.

Authors:  E C Hsu; F Sarangi; C Iorio; M S Sidhu; S A Udem; D L Dillehay; W Xu; P A Rota; W J Bellini; C D Richardson
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains.

Authors:  J S Rota; Z D Wang; P A Rota; W J Bellini
Journal:  Virus Res       Date:  1994-03       Impact factor: 3.303

5.  The human CD46 molecule is a receptor for measles virus (Edmonston strain).

Authors:  R E Dörig; A Marcil; A Chopra; C D Richardson
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Antibody-targeted cell fusion.

Authors:  Takafumi Nakamura; Kah-Whye Peng; Sompong Vongpunsawad; Mary Harvey; Hiroyuki Mizuguchi; Takao Hayakawa; Roberto Cattaneo; Stephen J Russell
Journal:  Nat Biotechnol       Date:  2004-02-15       Impact factor: 54.908

8.  Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines.

Authors:  V A Fulginiti; J J Eller; A W Downie; C H Kempe
Journal:  JAMA       Date:  1967-12-18       Impact factor: 56.272

9.  Detection of measles virus RNA in urine specimens from vaccine recipients.

Authors:  P A Rota; A S Khan; E Durigon; T Yuran; Y S Villamarzo; W J Bellini
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Rescue of measles viruses from cloned DNA.

Authors:  F Radecke; P Spielhofer; H Schneider; K Kaelin; M Huber; C Dötsch; G Christiansen; M A Billeter
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

View more
  23 in total

1.  Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus/measles virus.

Authors:  Yu-Ping Liu; Samuel P Russell; Camilo Ayala-Breton; Stephen J Russell; Kah-Whye Peng
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Hydrophobic and charged residues in the central segment of the measles virus hemagglutinin stalk mediate transmission of the fusion-triggering signal.

Authors:  Swapna Apte-Sengupta; Chanakha K Navaratnarajah; Roberto Cattaneo
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

3.  Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates.

Authors:  Yuta Shirogane; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

Review 4.  Connections matter--how viruses use cell–cell adhesion components.

Authors:  Mathieu Mateo; Alex Generous; Patrick L Sinn; Roberto Cattaneo
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

Review 5.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

6.  The Nectin-4/Afadin Protein Complex and Intercellular Membrane Pores Contribute to Rapid Spread of Measles Virus in Primary Human Airway Epithelia.

Authors:  Brajesh K Singh; Andrew L Hornick; Sateesh Krishnamurthy; Anna C Locke; Crystal A Mendoza; Mathieu Mateo; Catherine L Miller-Hunt; Roberto Cattaneo; Patrick L Sinn
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

7.  Different roles of the three loops forming the adhesive interface of nectin-4 in measles virus binding and cell entry, nectin-4 homodimerization, and heterodimerization with nectin-1.

Authors:  Mathieu Mateo; Chanakha K Navaratnarajah; Robin C Willenbring; Justin W Maroun; Ianko Iankov; Marc Lopez; Patrick L Sinn; Roberto Cattaneo
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

8.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

9.  Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.

Authors:  Fabrizio Angius; Heidi Smuts; Ksenia Rybkina; Debora Stelitano; Brian Eley; Jo Wilmshurst; Marion Ferren; Alexandre Lalande; Cyrille Mathieu; Anne Moscona; Branka Horvat; Takao Hashiguchi; Matteo Porotto; Diana Hardie
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 10.  Structural basis of efficient contagion: measles variations on a theme by parainfluenza viruses.

Authors:  Mathieu Mateo; Chanakha K Navaratnarajah; Roberto Cattaneo
Journal:  Curr Opin Virol       Date:  2014-02-01       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.